Proceedings of the National Academy of Sciences · 2009 · 99 citations · 35 references
Life SciencesImmunologyPathobiologyAutoimmunityInflammationInnate ImmunityAutoimmune DiseasesAutoimmune InflammationInflammatory Response RegulationInflammatory SignalingRegulation Of AutoimmunityToll-like ReceptorsAgonist ActivityExperimental Autoimmune EncephalomyelitisToll-like Receptor SignalingToll-like Receptor ToleranceToll-like Receptor-mediated Innate Immune ResponseToll-like Receptors In AutoimmunityToll-like Receptors In InflammationToll-like Receptors In Neuroinflammation
Activation of Toll-like receptors (TLR) contributes to the initiation and maintenance of chronic inflammation in autoimmune diseases, yet repeated exposure to a TLR agonist can induce hyporesponsiveness to subsequent TLR stimulation. Here, we used a synthetic TLR7 agonist, 9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine (SM360320, 1V136) to study TLR7 induced attenuation of inflammatory responses and its application to autoimmune diseases. Repeated low dose administration of this TLR7 agonist induced hyporesponsiveness or tolerance to TLR2, -7, and -9 activators and limited the course of neural inflammation in an experimental allergic encephalomyelitis model. The hyporesponsiveness did not depend on T or B lymphocytes, but did require bone marrow derived cells. In addition, TLR7 tolerance reduced inflammation in a passive antibody mediated arthritis model. TLR7 tolerance did not cause global immunosuppression, because susceptibility to Listeria monocytogenes infection was not altered. The mechanism of TLR7 tolerance involved the up-regulation of 2 inhibitors of TLR signaling: Interleukin 1 Receptor Associated Kinase (IRAK) M, and Src homology 2 domain-containing inositol polyphosphate phosphatase (SHIP)-1. These findings suggest that induction of TLR7 tolerance might be a new therapeutic approach to subdue inflammation in autoimmune diseases.
35
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Taro Kawai, Osamu Adachi, Tomohiko Ogawa et al. · Immunity · 1999 · 2.1K citations · Full text
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Koichi S. Kobayashi, Lorraine D. Hernandez, Jorge E. Galán et al. · Cell · 2002 · 1.3K citations · Full text
Franck J. Barrat, Thea Meeker, Josh Gregorio et al. · The Journal of Experimental Medicine · 2005 · 920 citations · Full text